| Synthetic lethality-mediated precision oncology via the tumor transcriptome JS Lee, NU Nair, G Dinstag, L Chapman, Y Chung, K Wang, S Sinha, ... Cell 184 (9), 2487-2502. e13, 2021 | 69 | 2021 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 41 | 2022 |
| A systematic analysis of the landscape of synthetic lethality-driven precision oncology AA Schäffer, Y Chung, AV Kammula, E Ruppin, JS Lee Med 5 (1), 73-89. e9, 2024 | 2 | 2024 |
| Accurate Spatial Gene Expression Prediction by integrating Multi-resolution features Y Chung, JH Ha, KC Im, JS Lee arXiv preprint arXiv:2403.07592, 2024 | | 2024 |
| A silver jubilee for synthetic lethality in cancer treatment: where do we stand JS Lee, Y Chung, AV Kammula, AA Schaffer, E Ruppin Cancer Research 83 (7_Supplement), 946-946, 2023 | | 2023 |
| A systematic analysis of the landscape of synthetic lethality-driven precision oncology A Alejandro, Y Chung, V Ashwin, ER Kammula, JS Lee | | |
